$AZN Market Cap:
Research Board Inbox Deep Research Not Interested Shortlisted

$AZN SEC Filings

Filing Filed On
FORM 6-K/A 30 Jul 2021
6-K/A 31 Jul 2020
AZ REPORTS PHASE III RESULTS FOR PT010 IN COPD 26 Jan 2018
POSITIVE RESULTS FROM BRODALUMAB PHASE III STUDY 26 Nov 2014
ASTRAZENECA UPDATES ON ONCOLOGY PIPELINE AT ASCO 03 Jun 2014
MARC DUNOYER APPOINTED CHIEF FINANCIAL OFFICER 31 Oct 2013